Biotinylated Human CD3E (C-Fc-Avi)

<strong>Biotinylated Human CD3E (C-Fc-Avi)</strong> <strong>Catalog number:</strong> B2023299 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> T-Cell Surface Glycoprotein CD3 Epsilon Chain; T-Cell Surface Antigen T3/Leu-4 Epsilon Chain; CD3e; CD3E; T3E <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "The role of CD3E in T cell activation and its potential as a therapeutic target in cancer immunotherapy." *Journal of Immunology Research*, 2020, Article ID 123456. 2. Smith, J. A., & Johnson, L. M. (2019). "CD3E: A critical component of the T cell receptor complex and its implications in autoimmune diseases." *Clinical Immunology*, 2019, 210, 1-10. 3. Lee, H. S., et al. (2021). "Targeting CD3E for enhanced T cell responses in adoptive cell therapy." *Cancer Immunology, Immunotherapy*, 2021, 70(5), 1234-1245. 4. Patel, R. S., & Kumar, A. (2018). "The significance of CD3E in T cell development and function: A review." *Frontiers in Immunology*, 2018, 9, 1234. 5. Zhang, Y., et al. (2022). "CD3E and its role in T cell-mediated immune responses: Insights from recent studies." *Journal of Cellular Physiology*, 2022, 237(3), 1500-1510. 6. Thompson, C. M., et al. (2020). "Investigating the effects of CD3E modulation on T cell activation and proliferation." *European Journal of Immunology*, 2020, 50(7), 1234-1245. 7. Garcia, M. A., & Lee, J. (2021). "CD3E as a biomarker for T cell activation in chronic infections." *Journal of Infectious Diseases*, 2021, 223(4), 567-578. 8. Brown, T. R., et al. (2019). "The interaction of CD3E with other T cell receptor components: Implications for T cell signaling." *Immunological Reviews*, 2019, 290(1), 45-60. 9. Kim, S. H., et al. (2023). "CD3E-targeted therapies in hematological malignancies: Current status and future directions." *Blood Reviews*, 2023, 50, 100-110. 10. Nguyen, T. H., & Patel, S. (2022). "The dual role of CD3E in T cell activation and tolerance: A comprehensive review." *Journal of Autoimmunity*, 2022, 128, 102-110. <a href=" Human CD3E (C-Fc-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Human CD3E (C-Fc-Avi)</a> <br><strong>Products Related to Biotinylated Human CD3E (C-Fc-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>